Stay updated on IDA53 Clinical Trial

Sign up to get notified when there's something new on the IDA53 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IDA53 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for the study of ibrutinib plus daratumumab in relapsed or refractory chronic lymphocytic leukemia with p53 dysfunction is now displayed, including its study design, participant criteria, and outcome measures.
    Difference
    64%
    Check dated 2026-11-10T15:08:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:00:27.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A notice about NIH’s website transition and terminology appears above the page, while the site revision changes from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T15:45:47.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T15:13:41.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study content, effectively blocking access to the study record and related details. This prevents viewing the study information until access is restored.
    Difference
    19%
    Check dated 2026-09-22T22:10:45.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a minor update to the page's publication history. This change does not alter the study content or data.
    Difference
    0.0%
    Check dated 2026-09-15T22:02:17.000Z thumbnail image

Stay in the know with updates to IDA53 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IDA53 Clinical Trial page.